Edition:
United States

Global Markets Headlines

Pfizer-AstraZeneca deal not quite dead yet

Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.

Photo

U.S. national monument review to test key land protection law

WASHINGTON U.S. Interior Secretary Ryan Zinke will recommend on Aug. 24 whether to eliminate or shrink nearly two dozen national monuments, creating the first major test for a 111-year-old law that gives presidents the power to protect swaths of public land.